Notes in Meningioma

To Subscribe, use this Key

Status	Last Update	Fields
Published	02/18/2024	CNS \| Menignioma \| 1.1 \| Epidemiology
Published	02/18/2024	CNS \| Meningioma \| 1.2 \| Aetiology
Published	02/18/2024	CNS \| Meningioma \| 1.3 \| Biologic behaviour
Published	02/18/2024	CNS \| Meningioma \| 1.4 \| Macroscopic appearance
Published	02/18/2024	CNS \| Meningioma \| 1.6 \| Classification
Published	02/18/2024	CNS \| Meningioma \| 1.7 \| Prognostic factors
Published	02/18/2024	CNS \| Meningioma \| 1.7.1 \| Clinical presentation
Published	02/18/2024	CNS \| Meningioma \| 1.7.2 \| Radiologic appearance
Published	02/18/2024	CNS \| Meningioma \| 1.9 \| DDx
Published	02/18/2024	CNS \| Meningioma \| 2 \| Workup
Published	02/18/2024	CNS \| Meningioma \| 3.1 \| Management
Published	02/18/2024	CNS \| Meningioma \| 3.2 \| Management \| Observation
Published	02/18/2024	CNS \| Meningioma \| 3.3 \| Surgical resection
Published	02/18/2024	CNS \| Meningioma \| 3.4.1 \| Radiotherapy
Published	02/18/2024	CNS \| Meningioma \| 3.4.2 \| Adjuvant RT \| Low risk
Published	02/18/2024	CNS \| Meningioma \| 3.4.3 \| Adjuvant RT \| Intermediate risk
Published	02/18/2024	CNS \| Meningioma \| 3.4.4 \| Adjuvant RT \| High risk
Published	02/18/2024	CNS \| Meningioma \| 3.4.5 \| Adjuvant RT \| Dose
Published	02/18/2024	CNS \| Meningioma \| 3.4.6 \| Stereotactic radiotherapy
Published	02/18/2024	CNS \| Meningioma \| 3.4.7 \| Recurrent disease
Published	02/18/2024	CNS \| Meningioma \| 3.4.8 \| Special sites
Published	02/18/2024	CNS \| Meningioma \| 3.5 \| Systemic therapy
Published	02/18/2024	CNS \| Meningioma \| 4.1 \| Follow up
Published	02/18/2024	CNS \| Meningioma \| 4.2 \| Outcomes
Published	02/18/2024	CNS \| Meningioma \| 5 \| RT technique
Published	02/18/2024	CNS \| Meningioma \| 5 \| RT technique \| SRS
Status	Last Update	Fields